Ichthyosis with confetti (IWC) is a genodermatosis associated with dominant-negative variants in keratin 10 (KRT10) or keratin 1 (KRT1). These frameshift variants result in extended aberrant proteins, localized to the nucleus rather than the cytoplasm. This mislocalization is thought to occur as a result of the altered carboxy (C)-terminus, from poly-glycine to either a poly-arginine or -alanine tail. Previous studies on the type of C-terminus and subcellular localization of the respective mutant protein are divergent. In order to fully elucidate the pathomechanism of IWC, a greater understanding is critical. This study aimed to establish the consequences for localization and intermediate filament formation of altered keratin 10 (K10) C-termini. To achieve this, plasmids expressing distinct KRT10 variants were generated. Sequences encoded all possible reading frames of the K10 C-terminus as well as a nonsense variant. A keratinocyte line was transfected with these plasmids. Additionally, gene editing was utilized to introduce frameshift variants in exon 6 and exon 7 at the endogenous KRT10 locus. Cellular localization of aberrant K10 was observed via immunofluorescence using various antibodies. In each setting, immunofluorescence analysis demonstrated aberrant nuclear localization of K10 featuring an argininerich C-terminus. However, this was not observed with K10 featuring an alanine-rich C-terminus. Instead, the protein displayed cytoplasmic localization, consistent with wild-type and truncated forms of K10. This study demonstrates that, of the various 3′ frameshift variants of KRT10, exclusively arginine-rich C-termini lead to nuclear localization of K10. K E Y W O R D S alanine-rich C-terminus, arginine-rich C-terminus, carboxy terminus, ichthyosis with confetti, keratin 10, KRT10, nuclear localization | 8443 RENZ Et al. S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Renz P, Imahorn E, Spoerri I, et al. Arginine-but not alanine-rich carboxy-termini trigger nuclear translocation of mutant keratin 10 in ichthyosis with confetti. J
| INTRODUC TI ON
Ichthyosis with confetti (IWC), also termed congenital reticular ichthyosiform erythroderma (CRIE) or ichthyosis variegata (OMIM #609165), is a keratinopathy associated with dominant-negative frameshift variants in keratin 10 (KRT10) and keratin 1 (KRT1). 1, 2 Skin of affected patients demonstrates generalized erythroderma, persisting throughout life. The disease is characterized by the appearance of numerous patches of pale, healthy-appearing skin in most patients during childhood. These increase in size and number with age. [3] [4] [5] Currently, 57 patients from 40 families (49% male, 51% female) have been reported (Table 1 ). Of these, 50 were sequenced.
The majority of these individuals (69%) display a heterozygous variant in KRT10 (familial 82%), whereas 31% carry a heterozygous variant in KRT1 (familial 18%).
Keratins comprise the components of the epithelial cytoskeleton. Acidic (type I) and basic (type II) keratins heterodimerize and subsequently assemble to form intermediate filaments (IFs). 6 Epidermal keratinocytes specifically co-express keratins as pairs in a differentiation-dependent manner. Keratinocytes of the proliferative basal layer express keratin (K) 5 and K14. The differentiating suprabasal epidermal layers are associated with the down-regulation of K5/K14 and expression of thicker K1/K10 filament bundles. 7 All currently described IWC-associated variants are deletions, insertions or duplications located within the helix-termination-motif or in the V2 domain of either K10 or K1 (Table 1) . Each results in frameshifts, leading to the translation of aberrant-truncated protein tails. Nonsense variants in the V2 domain of either K10 or K1 have not been reported. Variants leading to −2/+1 frameshifts within regions encoding the V2 domain are predicted to alter the downstream amino acid code from native glycine-to arginine-rich sequences.
Arginine-rich sequences frequently function as nuclear localization signals. 8, 9 Therefore, aberrant arginine-rich K10 or K1 tails might be responsible for the pathogenic nuclear localization of K10 or K1, characteristic of IWC.
Two studies suggested that alanine-rich K10 tails might also lead to nuclear K10 localization. 10, 11 In contrast to arginine, alanine-rich sequences have not been described to function as nuclear localization signal. 12 Lim et al, 10 suggested that a KRT10 frameshift variant at the exon 6/intron 6 boundary resulted in an alanine-rich tail. However, the original c.1373delG nomenclature for this variant should rather be annotated as c.1373+1delG, according to the sequence variant nomenclature HGVS, 13 resulted in an alanine-rich K10 tail. However, the variant was later on corrected to c.1544dupG and has been suggested to result in an arginine-rich K10 tail. 14 In support of a non-nuclear localizing signal of alanine-rich keratin tails, frameshift variants in KRT1, leading to alanine-rich tails, are reported to cause ichthyosis hystrix Curth-Macklin (IHCM) 15, 16 and striate palmoplantar keratoderma (SPPK). 17 Keratinocytes of these patients do not display nuclear localization of aberrant K1 products. 16 The aim of this study was to clarify the effects of mutant K10 tail variants on the pathogenic nuclear localization of the protein.
In order to elucidate this, we established two distinct cell culture models. The first model (transgenic model) centred on the transient expression of N-terminal eGFP-labelled K10 cDNA or gDNA, featuring mutant K10 tail variations, in an immortalized wild-type human keratinocyte line (NKc21). This model enabled determination of the subcellular localization of K10 translated from IWC-associated alleles. In vivo, the effects of KRT10 variants are not observable in undifferentiated keratinocytes. Endogenous regulation of KRT10 expression ensures equal ratios of mutant and wild-type K10.
Therefore, a context more closely resembling the in vivo situation enabled better analysis of the effect of IWC-associated alleles. This was achieved through the second model (endogenous model), generated via CRISPR/Cas9-mediated gene editing, which featured these variants at the endogenous KRT10 locus in NKc21 keratinocytes.
This study elucidates the relationship between K10 C-termini variants and K10 nuclear localization. The influence of C-termini variants on keratinocyte differentiation, K10 polymerization with assembly partners and the intracellular localization of these polymers were additionally characterized.
| MATERIAL AND ME THODS

| Plasmids and transfection
cDNA-derived KRT10 was PCR-generated from epidermal mRNA isolated from an IWC patient 3 (p5_arg_c_GFP) or a healthy control (p2_ wt_c_GFP). This was cloned into XhoI and HindIII sites of the pEGFP-C1 vector (Clontech Laboratories Inc Takara). Sequences encoding the alanine-rich C-terminus (p10_ala_c_GFP) or a premature stop (p13_ter_c_ GFP) were inserted into p2_wt_c_GFP via site-directed mutagenesis (GenScript ® ). Genomic DNA-derived KRT10 from a healthy control was cloned into pUC19 in two steps following amplification of KRT10 as 3′ and 5′ products. Initially, intron 5 to 3′-UTR gDNA was inserted into the HincII and HindIII restriction sites of pUC19 (pUC_K10-ex5-3′).
Subsequently, the 5′ product (mid of exon 1 to exon 4) was introduced into the SacI and HincII restriction sites of pUC_K10-ex5-3′. This combined product (pUC-K10) was inserted into the SacI and HindIII restriction sites of p2_wt_c_GFP, exchanging cDNA between mid of exon 1 to 3′-UTR for a complete gDNA sequence. This wild-type gDNA construct (p1_wt_g_GFP) contained a common 12 bp deletion in exon 7 (rs778613907) 5 enabling it to be distinguished from endogenous KRT10 of NKc21. The IWC100 variant 10 (c.1373+1delG) (p4_var_g_GFP) was inserted via site-directed mutagenesis (GenScript ® ). Subconfluent NKc21 keratinocytes were transfected with p1_wt_g_GFP or p4_var_g_GFP to receive the differentially spliced KRT10 mRNA. After full-length PCR and separation on 1% agarose gel, they were cloned into pEGFP-C1 using XhoI and HindIII restriction sites ( Figure 1A ). To distinguish the KRT10 wt , KRT10 arg and KRT10 ala products following combined transfection in cell imaging analyses, eGFP in p6_arg_s_GFP and p11_ala_s_GFP was replaced with mCherry. Constructs are summarized in Table S1 and Figure S1 . NKc21 keratinocytes were transfected with Xfect transfection reagent (Takara Bio Europe) as previously described. 18 Transfected cells were seeded on coverslips 48 hours post-treatment and subsequently fixed 24 hours later with 4% formaldehyde. Transfection rates were approximately 30%.
| Cell culture
Keratinocyte line NKc21 (kindly provided by Hans Törmä) 19 was grown in CnT-PR (CELLnTEC). Cells were cultured in a humid atmosphere at 37°C and 5% CO 2 . Integrity of cells and chromosomes was validated by SNP array (Illumina, HumanOmniExpressExome-8v1-3).
Mouse 3T3-J2 fibroblasts (ATCC) were grown in DMEM (Lonza)
supplemented with antibiotic-antimycotic and 10% foetal calf serum (ThermoFisher Scientific Inc). Feeder cells were generated from this cell line following mitomycin C (StressMarq Biosciences) treatment (4 mg/mL for 2 hours). These were subsequently used in keratinocyte single-cell cloning.
| CRISPR-Cas9-mediated gene editing and single-cell cloning
Plasmid pSpCas9(BB)-2A-GFP (PX458) (kindly gifted from Feng Zhang, Addgene plasmid #48138) was used for generation of GFP-labelled Cas9 vectors. 20 In brief, the sgRNA oligos were ligated into pSpCas9(BB)-2A-GFP after digestion with restriction enzyme BbsI. These resulted vectors carried either guide RNA cr26 (GGCGGCGGAAGTTTCGGCGG, KRT10, exon 7) or cr33 (GCCTGCTAGAAGGAGAGGGA KRT10, exon 6). Plasmids were transfected with Xfect polymer (Takara Bio) as previously described. 18 Briefly, 70 000 keratinocytes per well were seeded in 6-well plates. One day later, a mixture of 660 ng of CRISPR/Cas9 plasmid, 0.2 µL Xfect polymer and 100 µL Xfect buffer was incubated at room temperature for 10 minutes and added to the keratinocytes. After 4 hours at 37°C, the medium was exchanged. Individual GFP-fluorescent cells were FACSorted 72 hours later on an Aria II cell sorter (BD Biosciences) using 100 µm nozzle and 15 psi pressure. They were co-cultivated with mouse 3T3-J2 feeder fibroblasts (ATCC) 21 previously arrested with 4 g L −1 mitomycin C (StressMarq Biosciences) in 96-well plates. Clones were subsequently expanded.
Corresponding sequence data on KRT10 are summarized in Table S2 .
| Keratinocyte differentiation and epidermal equivalent formation
Since KRT10 is only expressed in differentiated cells, differentiation was induced in confluent cultures in the absence of growth factors and at high calcium concentration (1.2 mM). For mRNA isolation, keratinocytes were cultured in CnT-PR medium (CELLnTEC). One day before expected confluency, medium was exchanged to CnT-PR-D ANOVA tests were used for statistical analysis. (Table S3 ). Sanger sequencing was performed by an external vendor (Microsynth AG).
| Sequencing of gDNA and RNA
| Ratio of mRNA p9_arg_s_GFP and p11_ala_s_ GFP
AB 3130 Genetic Analyzer was used to determine the ratio of KRT10 arg (p9_arg_s_GFP) and KRT10 ala (p11_ala_s_GFP) mRNA within PCR products ( Figure 1 ) by fragment analysis as previously described. 22 In brief, PCR was performed on cDNA following p4_var_g_GFP transfection with one FAM-labelled primer. This was stopped after 30 cycles to stay in the log phase of amplification. GeneScan™ 500 ROX™ (ThermoFisher Scientific Inc) was used as size standard. Quantitative assessment of PCR product was achieved following calculation of areas under the curve using GeneMapper.
| Immunofluorescence staining
Immunofluorescence staining was performed as previously described both on keratinocytes containing the respective plasmid grown on coverslips and on formalin-fixed and paraffin-embedded (FFPE-slides) keratinocytes of the epidermal models. 3 In brief, samples were blocked in donkey serum and tri- 
| RE SULTS
| IWC-associated KRT10 variants result in an arginine-rich C-terminus
NKc21 keratinocytes were transfected with KRT10 gDNA constructs, featuring either wild-type (p1_wt_g_GFP) or a previously described IWC-associated splice site variant (p4_var_g_GFP) 10 to investigate the presence and composition of potential additional splice products (Table S1 ). The wild-type construct resulted in the transcription of one main mRNA product of the expected size (2.1 kb) (wt_s). In contrast, the construct encoding the IWCcausing sequence resulted in four major mRNA products, of differing sizes ( Figure 1A) . Each mRNA was distinct (Table S1, Figure   S1 p14_ter_s_GFP) contained the complete intron 6, resulting in a shifted reading frame with a stop codon after 4 bp of intron 6.
The fourth product contained two sequences, with the majority of products displaying a 5 bp deletion of the 3′-terminus of exon 6 (r.1369_1373del, p.Gly457PhefsTer118; subcloned in p9_ arg_s_GFP) leading to K10 arg expression. A minority of products displayed a deletion of the last nucleotide of exon 6 (r.1373del; subcloned in p11_ala_s_GFP), encoding K10 ala (p.Ser458IlefsTer157).
Quantitative assessment of an unsaturated PCR enabled relative PCR quantification and revealed 66% KRT10 arg (p9_arg_s_GFP) and 33% KRT10 ala (p11_ala_s_GFP) products ( Figure 1B) .
In summary, the majority of identified mRNAs resulting from p4_var_g_GFP encoded an aberrant K10 arg (p6_arg_s_GFP, p8_
arg_s_GFP, p9_arg_s_GFP 
| Nuclear translocation of K10 is initiated by an arginine-rich C-terminus
The consequence of IWC-associated KRT10 variants on cellular localization was initially analysed in vitro. Plasmids encoding eGFPlabelled KRT10 cDNA were generated. These carried previously reported IWC-associated frameshift variants described to result in each alternate reading frame (−2/+1 or −1/+2). 3 
| Endogenous expression of aberrant K10 leads to abnormal differentiation of keratinocytes in culture
Keratinocyte clones were generated via CRISPR/Cas9-mediated gene editing enabling the introduction of heterozygous −2/+1 (KRT10 arg ) or −1/+2 (KRT10 ala ) frameshifts into regions encoding the V2 domain. As a result, variants similar to those found in IWC patients were generated in NKc21 keratinocytes. This enabled the analysis of aberrant K10 subcellular localization in an endogenous setting. Six clones with heterozygous frameshift variants were studied. Four displayed expression K10 arg (e1_arg_33-1, e2_arg_33-1, e3_arg_26-1, e4_arg_26-1), and two demonstrated expression K10 ala (e5_ala_26-1, e6_ala_26-1) ( Table S2 ). Sequencing of cDNA derived from differentiated cells confirmed transcription of the expected KRT10 mRNAs (Table S2) .
Epidermal equivalents derived from K10 arg single-cell clones were subjected to haematoxylin and eosin (HE) staining. These displayed stratified epithelium including: basal layer, differentiated suprabasal layers and stratum corneum comparable to wild-type and mock controls ( Figure 5A-C) . However, epidermal equivalents derived from K10 ala clones displayed an epithelium with strongly impaired differentiation and significantly thinner than epidermal equivalents from K10 arg and K10 wt (Figure 5D , Figure S5 ). 
| D ISCUSS I ON
In keratinocytes derived from IWC patients, K10 displays nuclear localization, correlated with −2/+1 frameshift variants (K10 arg ).
However, the effect of K10 ala was previously inconclusive.
Approximately 70% of IWC patients carry KRT10 frameshift variants.
These affect splice sites in 60% of cases. Of the currently reported IWC-associated KRT10 splice site variants, approximately 30% affect the donor splice site of intron 6. Analysis of mRNA from patients with IWC-associated splice site variants revealed transcripts that would be translated into K10 with arginine-rich tails. 1 These results contradict a previous suggestion that K10 ala may cause pathogenicity in an IWC patient with a splice site variant. 10 However, sequencing of the corresponding cDNA was not previously performed to confirm a frameshift at the level of transcription. Human splice sites are highly conserved; >99.9% are canonical (donor site: GT, GC, AT). 23 Further, exonic sequences close to the exon-intron boundaries are highly conserved. The 3′-most exonic nucleotide is a guanine in over 80% of instances. [24] [25] [26] Analysis of splicing products from gDNA harbouring this variant revealed five transcripts. Three of these encoded K10 arg , one encoded K10 ter , and a minor transcript encoded K10 ala at the limit of detection. The presence of these transcript varieties concurs with splice site prediction tools. However, a similar in vivo splicing profile could only be confirmed in patient epidermal biopsies.
In addition to the patient described by Lim et al, 10 . In K10 wt -or K10 ala -derived equivalents, K10 was localized exclusively in the cytoplasm. Nuclear cotranslocation of endogenous K10 wt and K10 arg (e4_arg_26-1) enabled observation of nuclear localization via the C-terminus-specific anti-K10 (white arrowhead). DAPI (blue) was used for nuclear staining. Border between supporting filter membrane and basal layer indicated (white-dotted line). Scale bar, 20 μm an alanine-rich C-terminus results in the severe phenotype of IHCM 15, 16, 29 or SPPK, 17 no patients have been described with K10 ala -associated variants. This is in line with our data of an impaired differentiation in K10 ala keratinocytes, which might result in lethality.
Keratins promiscuously form heterodimers consisting of equimolar amounts of type I and type II keratins. 6 
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